Yaba Poisoning - Management
Yaba ("crazy medicine" in Thai) is a tablet combination of methamphetamine + caffeine, common in Southeast Asia. Poisoning presents as an amphetamine/sympathomimetic toxidrome, and treatment follows standard methamphetamine toxicity management - there is no specific antidote.
Clinical Presentation
Tachycardia, hypertension, diaphoresis, hyperthermia, mydriasis, and mental status changes ranging from anxiety/agitation to agitated delirium or psychosis. End-organ complications include seizures, intracranial hemorrhage/stroke, chest pain (aortic dissection, MI), and rhabdomyolysis (Washington Manual of Medical Therapeutics, p. 1091).
Rx / Treatment Approach
1. Resuscitation and monitoring (ABCs)
- IV access, cardiac monitoring, pulse oximetry, continuous observation.
- ECG (watch for sinus tachycardia or ventricular dysrhythmias).
- In altered mental status: check glucose, consider naloxone and thiamine if the picture is unclear (co-ingestion cannot be excluded) - Harrison's Principles of Internal Medicine, p. 3750.
2. Sedation - mainstay of therapy
- Benzodiazepines (e.g., diazepam or lorazepam), titrated to control agitation and normalize vital signs, are first-line.
- If psychosis/mania predominates, an antipsychotic (e.g., haloperidol, ziprasidone) can be added - Harrison's notes dopamine receptor antagonists are useful for the central dopaminergic effects of methamphetamine.
- Avoid pure beta-blockade as monotherapy (risk of unopposed alpha-adrenergic vasoconstriction) - control BP/HR primarily through adequate sedation.
3. Hyperthermia
- Aggressive external cooling (cooling blankets, evaporative cooling, ice packs) plus deeper sedation.
- In severe/refractory hyperthermia: paralysis with a non-depolarizing neuromuscular blocker plus intubation may be required.
4. Blood pressure / cardiovascular control
- If tight BP control is needed (aortic dissection, intracranial hemorrhage, acute MI), use rapidly titratable agents such as nicardipine, clevidipine, or nitroglycerin rather than beta-blockers alone.
5. Fluids and rhabdomyolysis
- IV crystalloid resuscitation is reasonable in all significant cases and mandatory if rhabdomyolysis is present, to protect renal function.
6. Seizures
- Treat with benzodiazepines as first line, as in other sympathomimetic toxidromes.
7. Investigations to guide care
- Basic metabolic panel, troponin, creatine kinase (rhabdomyolysis, renal injury, myocardial ischemia).
- CT brain if significant mental status change or headache (rule out hemorrhage/stroke).
- CT angiogram chest if chest pain concerning for dissection.
- Urine drug screen has little value for acute management decisions.
8. Disposition
- Psychiatric symptoms (mania/psychosis) can persist for weeks after the drug clears - patients may need psychiatric evaluation/admission even after the acute toxidrome resolves.
There is no reversal agent - management is entirely supportive, targeting sedation, cooling, cardiovascular stabilization, and end-organ complication surveillance (Washington Manual of Medical Therapeutics, pp. 1091-1092; Harrison's Principles of Internal Medicine, p. 3750).
A targeted PubMed check for recent systematic reviews on methamphetamine toxicity management (last 2 years) did not return any papers that revise this supportive-care approach - the closest hits concerned prenatal exposure outcomes (PMID 40626732) and methamphetamine-HIV neurotoxicity mechanisms (PMID 39224601), neither of which changes acute ED management.
If this is for an exam/clinical toxicology context in Bangladesh/South Asia specifically (where "Yaba" terminology is used), the acute management protocol is identical to methamphetamine intoxication described above - let me know if you want dosing specifics (e.g., lorazepam/diazepam mg ranges) or a comparison with cocaine/MDMA toxidromes.